IL151126A0 - Carbocyclic side chain containing metalloprotease inhibitors - Google Patents
Carbocyclic side chain containing metalloprotease inhibitorsInfo
- Publication number
- IL151126A0 IL151126A0 IL15112601A IL15112601A IL151126A0 IL 151126 A0 IL151126 A0 IL 151126A0 IL 15112601 A IL15112601 A IL 15112601A IL 15112601 A IL15112601 A IL 15112601A IL 151126 A0 IL151126 A0 IL 151126A0
- Authority
- IL
- Israel
- Prior art keywords
- side chain
- chain containing
- metalloprotease inhibitors
- containing metalloprotease
- carbocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/06—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings
- C07D265/08—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D265/10—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with oxygen atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
- C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/08—1,3-Dioxanes; Hydrogenated 1,3-dioxanes condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyrrole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19105900P | 2000-03-21 | 2000-03-21 | |
PCT/US2001/008784 WO2001070682A2 (fr) | 2000-03-21 | 2001-03-20 | Chaine laterale carbocyclique contenant des inhibiteurs de metalloproteases |
Publications (1)
Publication Number | Publication Date |
---|---|
IL151126A0 true IL151126A0 (en) | 2003-04-10 |
Family
ID=22703974
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15112601A IL151126A0 (en) | 2000-03-21 | 2001-03-20 | Carbocyclic side chain containing metalloprotease inhibitors |
Country Status (21)
Country | Link |
---|---|
US (1) | US20030162778A1 (fr) |
EP (1) | EP1265887A2 (fr) |
JP (1) | JP2003528078A (fr) |
KR (1) | KR20030005229A (fr) |
CN (1) | CN1418209A (fr) |
AR (1) | AR030196A1 (fr) |
AU (1) | AU2001249269A1 (fr) |
BR (1) | BR0109354A (fr) |
CA (1) | CA2403778A1 (fr) |
CZ (1) | CZ20023179A3 (fr) |
HU (1) | HUP0300998A3 (fr) |
IL (1) | IL151126A0 (fr) |
MA (1) | MA25783A1 (fr) |
MX (1) | MXPA02009310A (fr) |
NO (1) | NO20024482D0 (fr) |
PE (1) | PE20011187A1 (fr) |
PL (1) | PL357275A1 (fr) |
RU (1) | RU2002128003A (fr) |
SK (1) | SK13362002A3 (fr) |
WO (1) | WO2001070682A2 (fr) |
ZA (1) | ZA200206299B (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7576222B2 (en) | 2004-12-28 | 2009-08-18 | Wyeth | Alkynyl-containing tryptophan derivative inhibitors of TACE/matrix metalloproteinase |
Family Cites Families (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4743587A (en) * | 1985-09-10 | 1988-05-10 | G. D. Searle & Co. | Hydroxamic acid based collagenase inhibitors |
US4771038A (en) * | 1986-01-21 | 1988-09-13 | Ici Americas Inc. | Hydroxamic acids |
DK77487A (da) * | 1986-03-11 | 1987-09-12 | Hoffmann La Roche | Hydroxylaminderivater |
ZW23187A1 (en) * | 1986-12-15 | 1988-06-29 | Hoffmann La Roche | Phosphinic acid derivatives |
US5183900A (en) * | 1990-11-21 | 1993-02-02 | Galardy Richard E | Matrix metalloprotease inhibitors |
US5892112A (en) * | 1990-11-21 | 1999-04-06 | Glycomed Incorporated | Process for preparing synthetic matrix metalloprotease inhibitors |
GB9102635D0 (en) * | 1991-02-07 | 1991-03-27 | British Bio Technology | Compounds |
AU2228292A (en) * | 1991-06-14 | 1993-01-12 | Research Corporation Technologies, Inc. | Peptide derivatives of collagenase inhibitor |
JPH05125029A (ja) * | 1991-11-06 | 1993-05-21 | Yamanouchi Pharmaceut Co Ltd | 新規なアミド化合物又はその塩 |
WO1993021942A2 (fr) * | 1992-05-01 | 1993-11-11 | British Biotech Pharmaceuticals Limited | Utilisation d'inhibiteurs de metalloprotease matricielle (mmp) |
US5318964A (en) * | 1992-06-11 | 1994-06-07 | Hoffmann-La Roche Inc. | Hydroxamic derivatives and pharmaceutical compositions |
US5326760A (en) * | 1992-06-29 | 1994-07-05 | Glaxo, Inc. | Aminobutanoic acid compounds having metalloprotease inhibiting properties |
GB9223904D0 (en) * | 1992-11-13 | 1993-01-06 | British Bio Technology | Inhibition of cytokine production |
US5506242A (en) * | 1993-01-06 | 1996-04-09 | Ciba-Geigy Corporation | Arylsufonamido-substituted hydroxamic acids |
US5455258A (en) * | 1993-01-06 | 1995-10-03 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamic acids |
US5646167A (en) * | 1993-01-06 | 1997-07-08 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamix acids |
JPH08500124A (ja) * | 1993-04-27 | 1996-01-09 | セルテック セラピューティックス リミテッド | メタロプロテイナーゼインヒビターとしてのペプチジル誘導体 |
WO1995004033A1 (fr) * | 1993-08-02 | 1995-02-09 | Celltech Limited | Derives de succinamide, methodes de preparation et utilisation en tant qu'inhibiteurs de gelatinase et de collagenase |
US5545735A (en) * | 1993-10-04 | 1996-08-13 | Merck & Co., Inc. | Benzo-Fused Lactams promote release of growth hormone |
US5470834A (en) * | 1993-10-06 | 1995-11-28 | Florida State University | Sulfoximine and suldodiimine matrix metalloproteinase inhibitors |
US5403952A (en) * | 1993-10-08 | 1995-04-04 | Merck & Co., Inc. | Substituted cyclic derivatives as novel antidegenerative agents |
GB9323165D0 (en) * | 1993-11-10 | 1994-01-05 | Chiros Ltd | Compounds |
ATE165817T1 (de) * | 1994-01-20 | 1998-05-15 | British Biotech Pharm | Metalloproteinaseinhibitoren |
GB9401129D0 (en) * | 1994-01-21 | 1994-03-16 | British Bio Technology | Hydroxamic acid derivatives as metalloproteinase inhibitors |
CA2181709A1 (fr) * | 1994-01-22 | 1995-07-27 | Raymond Paul Beckett | Derives de l'acide hydroxamique en tant qu'inhibiteurs de metalloproteinase |
US5514716A (en) * | 1994-02-25 | 1996-05-07 | Sterling Winthrop, Inc. | Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof |
US5665753A (en) * | 1994-03-03 | 1997-09-09 | Smithkline Beecham Corporation | Cytokine inhibiting imidazole substituted hydroxamic acid derivatives |
GB9405076D0 (en) * | 1994-03-16 | 1994-04-27 | Inst Of Ophtalmology | A medical use of matrix metalloproteinase inhibitors |
DE4411311A1 (de) * | 1994-03-31 | 1995-10-05 | Basf Ag | Verfahren zur Herstellung von lagerstabilen wäßrigen Lösungen von Vinylamin-Einheiten enthaltenden Polymerisaten |
GB9501737D0 (en) * | 1994-04-25 | 1995-03-22 | Hoffmann La Roche | Hydroxamic acid derivatives |
JPH10500986A (ja) * | 1994-05-28 | 1998-01-27 | ブリテッシュ バイオテック ファーマシューティカルズ リミテッド | 金属タンパク質分解酵素阻害剤 |
GB9411088D0 (en) * | 1994-06-03 | 1994-07-27 | Hoffmann La Roche | Hydroxylamine derivatives |
CA2193691A1 (fr) * | 1994-06-22 | 1995-12-28 | Andrew Miller | Inhibiteurs de metalloproteinases |
GB9416897D0 (en) * | 1994-08-20 | 1994-10-12 | British Biotech Pharm | Metalloproteinase inhibitors |
IL115995A0 (en) * | 1994-11-15 | 1996-01-31 | Bayer Ag | Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitors |
US5919940A (en) * | 1995-01-20 | 1999-07-06 | British Biotech Pharmaceuticals Limited | Metalloproteinase inhibitors |
US5886022A (en) * | 1995-06-05 | 1999-03-23 | Bayer Corporation | Substituted cycloalkanecarboxylic acid derivatives as matrix metalloprotease inhibitors |
US6124333A (en) * | 1995-06-22 | 2000-09-26 | British Biotech Pharmaceuticals Limited | Metalloproteinase inhibitors |
TW453995B (en) * | 1995-12-15 | 2001-09-11 | Novartis Ag | Certain alpha-substituted arylsulfonamido acetohydroxamic acids |
IL125378A0 (en) * | 1996-01-23 | 1999-03-12 | Shionogi & Co | Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
EP0927156A1 (fr) * | 1996-09-04 | 1999-07-07 | Warner-Lambert Company | Acides biphenyl-butyriques et leurs derives, utilises comme inhibiteurs des metalloproteases de matrice |
HUP0004595A3 (en) * | 1997-07-31 | 2001-12-28 | Procter & Gamble | Acyclic metalloprotease inhibitors |
US6225311B1 (en) * | 1999-01-27 | 2001-05-01 | American Cyanamid Company | Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors |
-
2001
- 2001-03-20 WO PCT/US2001/008784 patent/WO2001070682A2/fr not_active Application Discontinuation
- 2001-03-20 CZ CZ20023179A patent/CZ20023179A3/cs unknown
- 2001-03-20 SK SK1336-2002A patent/SK13362002A3/sk unknown
- 2001-03-20 BR BR0109354-1A patent/BR0109354A/pt not_active IP Right Cessation
- 2001-03-20 KR KR1020027012316A patent/KR20030005229A/ko not_active Application Discontinuation
- 2001-03-20 MX MXPA02009310A patent/MXPA02009310A/es unknown
- 2001-03-20 AR ARP010101308A patent/AR030196A1/es unknown
- 2001-03-20 JP JP2001568894A patent/JP2003528078A/ja not_active Withdrawn
- 2001-03-20 AU AU2001249269A patent/AU2001249269A1/en not_active Abandoned
- 2001-03-20 CN CN01806670A patent/CN1418209A/zh active Pending
- 2001-03-20 EP EP01922472A patent/EP1265887A2/fr not_active Withdrawn
- 2001-03-20 RU RU2002128003/04A patent/RU2002128003A/ru unknown
- 2001-03-20 PL PL01357275A patent/PL357275A1/xx not_active Application Discontinuation
- 2001-03-20 IL IL15112601A patent/IL151126A0/xx unknown
- 2001-03-20 CA CA002403778A patent/CA2403778A1/fr not_active Abandoned
- 2001-03-20 HU HU0300998A patent/HUP0300998A3/hu unknown
- 2001-03-21 PE PE2001000266A patent/PE20011187A1/es not_active Application Discontinuation
-
2002
- 2002-08-07 ZA ZA200206299A patent/ZA200206299B/xx unknown
- 2002-09-16 MA MA26820A patent/MA25783A1/fr unknown
- 2002-09-18 US US10/246,496 patent/US20030162778A1/en not_active Abandoned
- 2002-09-19 NO NO20024482A patent/NO20024482D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ZA200206299B (en) | 2003-02-19 |
JP2003528078A (ja) | 2003-09-24 |
SK13362002A3 (sk) | 2003-04-01 |
CA2403778A1 (fr) | 2001-09-27 |
PL357275A1 (en) | 2004-07-26 |
RU2002128003A (ru) | 2004-02-27 |
CZ20023179A3 (cs) | 2003-02-12 |
WO2001070682A2 (fr) | 2001-09-27 |
NO20024482L (no) | 2002-09-19 |
AR030196A1 (es) | 2003-08-13 |
MXPA02009310A (es) | 2003-03-12 |
HUP0300998A2 (hu) | 2003-07-28 |
US20030162778A1 (en) | 2003-08-28 |
NO20024482D0 (no) | 2002-09-19 |
AU2001249269A1 (en) | 2001-10-03 |
WO2001070682A3 (fr) | 2002-01-31 |
MA25783A1 (fr) | 2003-07-01 |
KR20030005229A (ko) | 2003-01-17 |
PE20011187A1 (es) | 2001-12-12 |
HUP0300998A3 (en) | 2004-10-28 |
EP1265887A2 (fr) | 2002-12-18 |
BR0109354A (pt) | 2003-04-15 |
CN1418209A (zh) | 2003-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL151124A0 (en) | Heterocyclic side chain containing metalloprotease inhibitors | |
IL146518A0 (en) | Metalloprotease inhibitors | |
IL157652A0 (en) | Metalloproteinase inhibitors | |
IL157570A0 (en) | Metalloproteinase inhibitors | |
IL150712A0 (en) | Matrix metalloproteinase inhibitors | |
IL157658A0 (en) | Metalloproteinase inhibitors | |
IL138738A0 (en) | Substituted pyrrolidine hydroxamate metalloprotease inhibitors | |
IL145085A0 (en) | Dihetero-substituted metalloprotease inhibitors | |
PL357277A1 (en) | Carbocyclic side chain containing, n-substituted metalloprotease inhibitors | |
IL151125A0 (en) | Heterocyclic side chain containing, n-substituted metalloprotease inhibitors | |
IL151250A0 (en) | Difluorobutyric acid metalloprotease inhibitors | |
AU7847901A (en) | Pyrrolidine derivatives as metalloprotease inhibitors | |
HUP0302904A3 (en) | Matrix metalloproteinase inhibitors | |
IL151126A0 (en) | Carbocyclic side chain containing metalloprotease inhibitors | |
SI1181017T1 (en) | Metalloprotease inhibitors | |
GB0015996D0 (en) | Inhibitors | |
GB0021193D0 (en) | Inhibitors | |
GB0029730D0 (en) | Inhibitors | |
GB0029733D0 (en) | Inhibitors |